Key result
Chronic NO synthesis inhibition with L-NAME exacerbated cyclosporin-induced increases in arterial pressure and renal resistances, suggesting NO synthesis counterbalances preglomerular vasoconstriction.
Why the study?
Does NO synthesis inhibition exacerbate cyclosporin nephrotoxicity in uninephrectomized rats?
Does NO synthesis inhibition exacerbate cyclosporin nephrotoxicity in uninephrectomized rats?
NO synthesis, likely driven by increased eNOS mRNA expression, is enhanced at the cortical level during cyclosporin nephrotoxicity to counterbalance preglomerular vasoconstriction.
Answers are grounded in this paper and cite their sources.
Should not alter cyclosporin use in patients; hypothesis-generating for NO-targeted renoprotection pending clinical trials.
The role of nitric oxide (NO) during cyclosporin renal vasoconstriction was evaluated by glomerular hemodynamic and histological changes produced by chronic NO synthesis inhibition and neuronal (nNOS), inducible (iNOS), and endothelial (eNOS) NO syntheses mRNA expression in renal cortex and medulla. Uninephrectomized rats treated during 7 days with vehicle (Veh), cyclosporin A (CsA) 30 mg/kg, CsA + nitro-L-arginine methyl ester (L-NAME), and Veh + L-NAME (10 mg/dl) in the drinking water were studied. Increase in arterial pressure and afferent and efferent resistances, as well as decrease in glomerular plasma flow, ultrafiltration coefficient, and single-nephron glomerular filtration rate were significantly greater with CsA + L-NAME than with CsA alone. The increase in afferent resistance was higher with CsA + L-NAME than with Veh + L-NAME. In addition, glomerular thrombosis, proximal tubular vacuolization, and arteriolar thickening were more prominent. In renal cortex, eNOS mRNA expression exhibited a 2.7-fold increase in CsA, whereas, in medulla, nNOS and iNOs expression were lower in CsA than in Veh, while eNOS tended to increase. Our results support the hypothesis that NO synthesis is enhanced at cortical level during CsA nephrotoxicity, counterbalancing predominantly preglomerular vasoconstriction. Higher NO production could be the result of increased eNOS mRNA expression.
No takes yet. Share an insight, caveat, or question.
Bobadilla et al. (1998) studied Cyclosporin nephrotoxicity. Cyclosporin A + nitro-L-arginine methyl ester (L-NAME) vs. Vehicle, CsA alone, and Vehicle + L-NAME was evaluated on Glomerular hemodynamic and histological changes, and NO synthases mRNA expression. Chronic NO synthesis inhibition with L-NAME exacerbated cyclosporin-induced increases in arterial pressure and renal resistances, suggesting NO synthesis counterbalances preglomerular vasoconstriction.
Synapse has enriched 10 related papers. Consider them for comparative context: